Vitamin Shoppe (NYSE: VSI) reported earnings on May 7. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended March 30 (Q1), Vitamin Shoppe met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue increased. Non-GAAP earnings per share expanded significantly. GAAP earnings per share increased.

Gross margins grew, operating margins dropped, net margins grew.

Revenue details
 Vitamin Shoppe logged revenue of $279.1 million. The 10 analysts polled by S&P Capital IQ predicted sales of $278.2 million on the same basis. GAAP reported sales were 13% higher than the prior-year quarter's $248.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.72. The 13 earnings estimates compiled by S&P Capital IQ anticipated $0.69 per share. Non-GAAP EPS of $0.72 for Q1 were 16% higher than the prior-year quarter's $0.62 per share. GAAP EPS of $0.68 for Q1 were 11% higher than the prior-year quarter's $0.61 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 36.4%, 80 basis points better than the prior-year quarter. Operating margin was 12.4%, 10 basis points worse than the prior-year quarter. Net margin was 7.5%, 10 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
 Next quarter's average estimate for revenue is $286.5 million. On the bottom line, the average EPS estimate is $0.63.

Next year's average estimate for revenue is $1.10 billion. The average EPS estimate is $2.35.

Investor sentiment
 The stock has a two-star rating (out of five) at Motley Fool CAPS, with 47 members out of 58 rating the stock outperform, and 11 members rating it underperform. Among 24 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 16 give Vitamin Shoppe a green thumbs-up, and eight give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Vitamin Shoppe is outperform, with an average price target of $61.18.

Is Vitamin Shoppe the right retailer for your portfolio? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average retailing powerhouse. Click here for instant access to this free report.